GSC
IDXX icon

G&S Capital’s Idexx Laboratories IDXX Stock Holding History

G&S Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,201
Closed -$580K – 123
2024
Q2 		$580K Buy
1,201
+629
+110% +$316K 0.25% 96
2024
Q1 		$309K Sell
572
-8
-1% -$4.37K 0.14% 110
2023
Q4 		$322K Sell
580
-562
-49% -$264K 0.15% 99
2023
Q3 		$499K Sell
1,142
-11
-1% -$5.49K 0.25% 93
2023
Q2 		$579K Buy
+1,153
New +$553K 0.28% 88

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

G&S Capital's IDXX Position: Q3 2024 in Review

G&S Capital sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 1,201 shares — an estimated $580K sold.

G&S Capital first reported a position in IDXX in Q2 2023 and held it in 5 quarters. The position peaked at $580K in Q2 2024. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • G&S Capital reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • G&S Capital sold 1,201 Idexx Laboratories shares in Q3 2024, an estimated $580K.
  • G&S Capital first reported a position in Idexx Laboratories in Q2 2023 and held it in 5 quarters.
  • G&S Capital's Idexx Laboratories position peaked at $580K in Q2 2024.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on G&S Capital's 13F filing for Q3 2024, filed 16 Oct 2024.